MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Provera 400mg tablets (Pfizer Ltd).

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Provera 5mg tablets (Pfizer Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Ponstan 250mg capsules (Chemidex Pharma Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Ponstan 250mg capsules (Chemidex Pharma Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Ponstan 250mg capsules (Chemidex Pharma Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Ponstan 250mg capsules (Chemidex Pharma Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Ponstan 250mg capsules (Chemidex Pharma Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Ponstan 250mg capsules (Chemidex Pharma Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Ponstan 250mg capsules (Chemidex Pharma Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.